ROFLUMILAST 0.50 mg
Argentine Industry - Rx only
Each film-coated tablet contains roflumilast 0.50 mg, lactose monohydrate, povidone K-90, corn starch, magnesium stearate, sunset yellow aluminium lake, Opadry II white.
Non-steroid anti-inflammatory agent; phosphodiesterase 4 (PDE4) inhibitor; treatment for airway obstructive diseases.
PLUSMUV® film-coated tablets for oral administration is indicated to reduce the risk of COPD exacerbations in patients with severe COPD (VEMS post-dilator less than 50 % of the normal) associated with chronic bronchitis in adults with a history of frequent exacerbations, and as additional therapy with bronchodilators.
Keep at room temperature (below 30 °C) protected from the light, in its marketed packing.
Cartons containing 10, 30, and 90 film-coated tablets
Cartons containing 500 film-coated tablets for use in hospitals
Medicinal speciality authorised by the Ministry of Health
Certificate No. 57399
Laboratorio DOSA S.A.
Girardot 1369, (C1427AKC) City of Buenos Aires, Argentina.
Pharmaceutical Director: María C. Terzo, Pharmacist.